Literature DB >> 23496351

Epidemiology, clinical features, and prognosis of elderly adults with severe forms of influenza A (H1N1.

José Garnacho-Montero1, Antonio Gutiérrez-Pizarraya, Juan A Màrquez, Rafael Zaragoza, Rosa Granada, Sergio Ruiz-Santana, Jordi Rello, Alejandro Rodríguez.   

Abstract

OBJECTIVES: To examine epidemiological and clinical data of individuals aged 65 and older with influenza virus A (H1N1) admitted to the intensive care unit (ICU) and to identify independent predictors of ICU mortality.
DESIGN: Prospective, observational, multicenter study to determine prognostic factors in individuals infected with influenza A (H1N1) admitted to the ICU.
SETTING: One hundred forty-eight Spanish ICUs. PARTICIPANTS: Individuals with influenza A (H1N1) confirmed using real-time polymerase chain reaction from April 2009 to July 2011. MEASUREMENTS: Individuals aged 65 and older were compared with younger individuals. A multivariate analysis was conducted to determine independent predictors of mortality in this population.
RESULTS: One thousand one hundred twenty individuals (129 (11.5%) aged 65) were included. Prevalence of chronic diseases was more common in older individuals. Viral pneumonitis was more frequent in individuals younger than 65 (70.5% vs 54.3%, P < .001). In older individuals, Acute Physiology and Chronic Health Evaluation II score (odds ratio (OR) = 1.11, 95% confidence interval (CI) = 1.11–1.20, P = .002), immunosuppression (OR = 3.66, 95% CI, 1.33–10.03, P = .01) and oseltamivir therapy initiated after 48 hours (OR = 3.32, 95% CI = 1.02–10.8, P = .04) were identified as independent variables associated with mortality. Corticosteroid use was associated with a trend toward greater mortality (OR = 2.39, 95% CI = 0.98–5.91, P = .06).
CONCLUSION: Individuals aged 65 and older with influenza A (H1N1) admitted to the ICU have a higher incidence of underlying diseases than younger individuals and differences in clinical presentation. Early oseltamivir therapy is associated with better outcomes in elderly adults.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23496351     DOI: 10.1111/jgs.12152

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  8 in total

1.  Repeated influenza vaccination for preventing severe and fatal influenza infection in older adults: a multicentre case-control study.

Authors:  Itziar Casado; Ángela Domínguez; Diana Toledo; Judith Chamorro; Jenaro Astray; Mikel Egurrola; María Amelia Fernández-Sierra; Vicente Martín; María Morales-Suárez-Varela; Pere Godoy; Jesús Castilla
Journal:  CMAJ       Date:  2018-01-08       Impact factor: 8.262

2.  Corticosteroids as adjunctive therapy in the treatment of influenza.

Authors:  Louise Lansbury; Chamira Rodrigo; Jo Leonardi-Bee; Jonathan Nguyen-Van-Tam; Wei Shen Lim
Journal:  Cochrane Database Syst Rev       Date:  2019-02-24

3.  Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome.

Authors:  Francisco Álvarez-Lerma; Judith Marín-Corral; Clara Vila; Joan Ramón Masclans; Francisco Javier González de Molina; Ignacio Martín Loeches; Sandra Barbadillo; Alejandro Rodríguez
Journal:  Crit Care       Date:  2016-10-23       Impact factor: 9.097

4.  Potential Cost-Effectiveness of an Influenza Vaccination Program Offering Microneedle Patch for Vaccine Delivery in Children.

Authors:  Carlos Wong; Minghuan Jiang; Joyce H S You
Journal:  PLoS One       Date:  2016-12-22       Impact factor: 3.240

5.  Evaluation of Pregnancy, Younger Age, and Old Age as Independent Risk Factors for Poor Hospitalization Outcomes in Influenza A (H1N1)pdm09 Virus a Decade After the Pandemic.

Authors:  Sathyamurthy P; Senthil Kumar Dhandapani N
Journal:  Cureus       Date:  2020-11-28

6.  Severe influenza A in a Tunisian ICU sentinel SARI centre: Epidemiological and clinical features.

Authors:  Amira Jamoussi; Samia Ayed; Takoua Merhabene; Hamdi Doghri; Jalila Ben Khelil; Mohamed Besbes
Journal:  PLoS One       Date:  2022-07-06       Impact factor: 3.752

7.  Do corticosteroids reduce the mortality of influenza A (H1N1) infection? A meta-analysis.

Authors:  Yi Zhang; Wenjie Sun; Erik R Svendsen; Song Tang; Raina C MacIntyre; Peng Yang; Daitao Zhang; Quanyi Wang
Journal:  Crit Care       Date:  2015-02-20       Impact factor: 19.334

8.  Risk factors for serious outcomes associated with influenza illness in high- versus low- and middle-income countries: Systematic literature review and meta-analysis.

Authors:  Brenda L Coleman; Shaza A Fadel; Tiffany Fitzpatrick; Sera-Melisa Thomas
Journal:  Influenza Other Respir Viruses       Date:  2017-12-02       Impact factor: 4.380

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.